Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2

Fig. 1

IHC analysis of ALKBH5 expression in epithelial ovarian cancer. ALKBH5 was predominantly localized in the (d) plasma membrane and (a, c, h) cytoplasm. The expression of ALKBH5 in different types of ovarian cancer samples. a Serous papillary adenocarcinoma (stage I); b Serous papillary adenocarcinoma (stage I); c Serous papillary adenocarcinoma (stage IV); d Serous papillary adenocarcinoma (stage IIIC); e Mucinous adenocarcinoma (stage IB); f Clear cell carcinoma (stage I); g Endometrioid adenocarcinoma (stage IB); h Endometrioid adenocarcinoma (stage IIIC); i Normal ovarian tissue. Original magnification, 200X. j PFS curves for ovarian cancer patients. k OS curves for ovarian cancer patients. l PPS curves for ovarian cancer patients. P < 0.05 was considered to be a statistically significant difference

Back to article page